MPM BIOIMPACT LLC
CIK 1687078 · Holdings on Jun 30, 2024 · First reported Aug 14, 2024
Top ten holdings
Q2 2024- CGEM20.73%
- INSM6.41%
- OLMA4.46%
- 46565G1044.03%
- CRNX3.88%
- MDGL3.10%
- IOVA2.95%
- NTRA2.94%
- MIRM2.62%
- RARE2.43%
Share classes counted separately53.55%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- INSMWeight increased · +4.09 pp2.32% → 6.41%Shares +84.60K (+15.94%)
- STROWeight decreased · -2.33 pp3.72% → 1.39%Shares -1.05M (-25.71%)
- IOVAWeight decreased · -2.29 pp5.24% → 2.95%Shares +166.71K (+7.58%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CGEMCULLINAN THERAPEUTICS INCCommon View history and evidence | $133.39M | 20.73% | 7.65M shares | 20.95% → 20.73%-0.22 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | INSMINSMED INCCommon View history and evidence | $41.23M | 6.41% | 615.39K shares | 2.32% → 6.41%+4.09 pp +84.60K (+15.94%) | Added | ↗▾ |
| 03 | OLMAOLEMA PHARMACEUTICALS INCCommon View history and evidence | $28.73M | 4.46% | 2.65M shares | 3.56% → 4.46%+0.90 pp +701.18K (+35.89%) | Added | ↗▾ |
| 04 | 46565G104ITEOS THERAPEUTICS INCCommon View history and evidence | $25.91M | 4.03% | 1.75M shares | 3.83% → 4.03%+0.20 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | CRNXCRINETICS PHARMACEUTICALS INCommon View history and evidence | $24.96M | 3.88% | 557.18K shares | 3.62% → 3.88%+0.26 pp +76.60K (+15.94%) | Added | ↗▾ |
| 06 | MDGLMADRIGAL PHARMACEUTICALS INCCommon View history and evidence | $19.94M | 3.10% | 71.19K shares | 2.64% → 3.10%+0.46 pp +9.79K (+15.94%) | Added | ↗▾ |
| 07 | IOVAIOVANCE BIOTHERAPEUTICS INCCommon View history and evidence | $18.98M | 2.95% | 2.37M shares | 5.24% → 2.95%-2.29 pp +166.71K (+7.58%) | Added | ↗▾ |
| 08 | NTRANATERA INCCommon View history and evidence | $18.93M | 2.94% | 174.81K shares | 2.54% → 2.94%+0.40 pp +2.40K (+1.39%) | Added | ↗▾ |
| 09 | MIRMMIRUM PHARMACEUTICALS INCCommon View history and evidence | $16.84M | 2.62% | 492.57K shares | Prior unavailable +492.57K | New | ↗▾ |
| 10 | RAREULTRAGENYX PHARMACEUTICAL INCommon View history and evidence | $15.64M | 2.43% | 380.55K shares | 1.84% → 2.43%+0.59 pp +134.96K (+54.95%) | Added | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| GERN GERON CORP | Non-derivative | -10,475,675 | -$34.57M | SEC filing ↗ | SEC filing ↗ |
| VRDN VIRIDIAN THERAPEUTICS INC | Non-derivative | -614,010 | -$10.75M | SEC filing ↗ | SEC filing ↗ |
| 03152W109 AMICUS THERAPEUTICS INC | Non-derivative | -718,970 | -$8.47M | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1687078 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 643506945
}Research all 44 reported holdings.
This page includes 30 of 44 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 44 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1687078","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1687078","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.